B. Magnani

发表

Dynamic electrophysiological behavior of human atria during paroxysmal atrial fibrillation.

G. Nollo, A. Capucci, G. Boriani, 1995, Circulation.

Benefit of Adding Low Molecular Weight Heparin to the Conventional Treatment of Stable Angina Pectoris A Double‐Blind, Randomized, Placebo‐Controlled Trial

A. Branzi, B. Magnani, G. Melandri, 1993, Circulation.

Amlodipine reduces transient myocardial ischemia in patients with coronary artery disease: double-blind Circadian Anti-Ischemia Program in Europe (CAPE Trial).

B. Magnani, J. Deanfield, J. Deanfield, 1994, Journal of the American College of Cardiology.

Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients

Walker, R. Collins, V. Fuster, 1994 .

Efficacy and tolerability in fully conscious patients of transvenous low-energy internal atrial cardioversion for atrial fibrillation.

A. Capucci, G. Boriani, M. Biffi, 1998, The American journal of cardiology.

Transvenous internal cardioversion for atrial fibrillation: a randomized study on defibrillation threshold and tolerability of asymmetrical compared with symmetrical shocks.

G. Boriani, M. Biffi, A. Branzi, 1999, International journal of cardiology.

Effects of coronary artery revascularization and perioperative myocardial infarction on left ventricular wall motion.

B. Magnani, G. Melandri, A. Maresta, 1987, International journal of cardiology.

Effects of the administration of an angiotensin-converting enzyme inhibitor during the acute phase of myocardial infarction in patients with arterial hypertension. SMILE Study Investigators. Survival of Myocardial Infarction Long-term Evaluation.

A. Bignamini, B. Magnani, A. Bignamini, 1999, American journal of hypertension.

Beta-blocker treatment guided by head-up tilt test in neurally mediated syncope

G. Boriani, M. Biffi, A. Branzi, 1997 .

Effects of the early administration of zofenopril on onset and progression of congestive heart failure in patients with anterior wall acute myocardial infarction. The SMILE Study Investigators. Survival of Myocardial Infarction Long-term Evaluation.

B. Magnani, E. Ambrosioni, C. Borghi, 1996, The American journal of cardiology.

Short- and long-term effects of early fosinopril administration in patients with acute anterior myocardial infarction undergoing intravenous thrombolysis: Results from the Fosinopril in Acute Myocardial Infarction Study

B. Magnani, P. Marino, E. Ambrosioni, 1998 .

Post acute myocardial infarction: the Fosinopril in Acute Myocardial Infarction Study (FAMIS).

B. Magnani, P. Marino, E. Ambrosioni, 1997, American journal of hypertension.

Clinical results of the Verapamil in Hypertension and Atherosclerosis Study

B. Magnani, A. Pessina, E. Rosei, 1997 .

Increased intralymphocytic sodium content in essential hypertension: an index of impaired Na+ cellular metabolism.

B. Magnani, E. Ambrosioni, L. Montebugnoli, 1981, Clinical science.

Comparative effects of candesartan and enalapril on left ventricular hypertrophy in patients with essential hypertension: the candesartan assessment in the treatment of cardiac hypertrophy (CATCH) study

A. Zanchetti, M. Muiesan, M. Salvetti, 2002, Journal of hypertension.

Prevalence of episodes of ST‐segment depression among mild‐to‐moderate hypertensive patients in northern Italy: The Cardioscreening Study

A. Zanchetti, B. Magnani, M. Stramba-Badiale, 1998, Journal of hypertension.

Current standard of care in patients affected by coronary heart disease in Italy: the MC'95 study.

A. Zanchetti, B. Magnani, C. Dal palù, 2002, Italian heart journal : official journal of the Italian Federation of Cardiology.

Role of Phenylalkylamine Calcium Antagonists in the Treatment of Ischaemic Heart Disease

B. Magnani, F. Tartagni, 1993 .

Randomised comparison of subcutaneous heparin, intravenous heparin, and aspirin in unstable angina

A. Branzi, G. Gensini, B. Magnani, 1995, The Lancet.

Cardiac injury as late toxicity of mediastinal radiation therapy for Hodgkin's disease patients.

F. Gherlinzoni, G. Frezza, P. Zinzani, 1996, Haematologica.

Echocardiographic evaluation of the response to afterload stress test in young asymptomatic patients with chronic severe aortic regurgitation: sensitivity of the left ventricular end-systolic pressure-volume relationship.

A. Branzi, C. Rapezzi, B. Magnani, 1984, Circulation.

Haemodynamic effects of metoprolol and intravenous nitroglycerin versus metoprolol alone in patients with acute myocardial infarction.

A. Branzi, B. Magnani, G. Melandri, 1987, European heart journal.

Haemodynamic effects of metroprotolol and intravenous nitroglycerin versus metroprolol alone in patients with acute myocardial infaction

A. Branzi, B. Magnani, G. Melandri, 1987 .

[Electrocardiogram in pulmonary embolism].

B. Magnani, A. Marzocchi, D. Bracchetti, 1977, Il Torace.

Survival of myocardial infarction long-term evaluation (SMILE) study: rationale, design, organization, and outcome definitions.

B. Magnani, E. Ambrosioni, C. Borghi, 1994, Controlled clinical trials.

23 ELSA, European Lacidipine Study on Atherosclerosis

G. Mancia, A. Zanchetti, M. Safar, 1993 .

Atherosclerosis and calcium antagonists: the VHAS. The Verapamil-Hypertension Atherosclerosis Study (VHAS) Investigators.

A. Zanchetti, B. Magnani, C. Dal palù, 1992, Journal of human hypertension.

Enhanced thrombolytic efficacy and reduction of infarct size by simultaneous infusion of streptokinase and heparin.

A. Branzi, B. Magnani, G. Melandri, 1990, British heart journal.

Short- and long-term effects of early fosinopril administration in patients with acute anterior myocardial infarction undergoing intravenous thrombolysis: results from the Fosinopril in Acute Myocardial Infarction Study. FAMIS Working Party.

B. Magnani, P. Marino, E. Ambrosioni, 1998, American heart journal.

The HOPE (Heart Outcomes Prevention Evaluation) Study: the design of a large, simple randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. The HOPE study investigators.

Janzen, A. M. Møller, D. Debanne, 1996, The Canadian journal of cardiology.

Peripheral Hemodynamic and Humoral Effects of Oral Zofenopril Calcium (SQ. 26,991) in Patients with Congestive Heart Failure

B. Magnani, S. Boschi, E. Ambrosioni, 1989, Journal of clinical pharmacology.

[Incidence, etiology and prognosis of chronic heart failure in a group of patients hospitalized during the period 1981-1985].

B. Magnani, M. Ribani, M. Fini, 1988, Cardiologia.

Intralymphocytic sodium concentration: a sensitive index to identify young subjects at risk of hypertension.

B. Magnani, E. Ambrosioni, C. Borghi, 1981, Clinical and experimental hypertension.

Effects of a low-salt diet and of acute salt loading on blood pressure and intralymphocytic sodium concentration in young subjects with borderline hypertension.

B. Magnani, E. Ambrosioni, L. Montebugnoli, 1981, Clinical science.

Early treatment of acute myocardial infarction with angiotensin-converting enzyme inhibition: safety considerations. SMILE pilot study working party.

B. Magnani, E. Ambrosioni, C. Borghi, 1991, The American journal of cardiology.

Evidence of a Partial Escape of Renin‐Angiotensin‐Aldosterone Blockade in Patients with Acute Myocardial Infarction Treated with Ace Inhibitors

A. Branzi, B. Magnani, S. Boschi, 1993, Journal of clinical pharmacology.

Hemodynamic effects of felodipine in congestive heart failure

A. Branzi, B. Magnani, S. Pancaldi, 1987, Cardiovascular Drugs and Therapy.

Usefulness of nicorandil in congestive heart failure.

G. Boriani, B. Magnani, S. Boschi, 1990, The American journal of cardiology.

Stable Angina Pectoris

A. Branzi, B. Magnani, G. Melandri, 2005 .

Thrombolytic Therapy in Acute Myocardial Infarction

B. Magnani, G. Melandri, F. Semprini, 1992 .

Cardiac Glycosides

B. Magnani, P. Malini, 1995, Drug safety.

Comparison of efficacy of low molecular weight heparin (parnaparin) with that of unfractionated heparin in the presence of activated platelets in healthy subjects.

A. Branzi, B. Magnani, G. Melandri, 1993, The American journal of cardiology.

Effects of two dosages of subcutaneous low molecular weight heparin (Parnaparin) and of unfractionated heparin on fibrin formation and lipolysis in acute myocardial infarction.

A. Branzi, B. Magnani, G. Melandri, 1992, Thrombosis research.

Antiarrhythmic Drug Administration before Electrical Cardioversion of Atrial Fibrillation: Is It Useful to Prevent Early Arrhythmia Recurrence?

A. Capucci, G. Boriani, M. Biffi, 1998 .

Captopril in mild heart failure: preliminary observations of a long-term, double-blind, placebo-controlled multicentre trial.

B. Magnani, C. Magelli, 1986, Postgraduate medical journal.

Captopril improves hemodynamic response to static exercise in patients with congestive heart failure: A double‐blind, placebo‐controlled, randomized trial

B. Magnani, E. Ambrosioni, F. Costa, 1990, Clinical cardiology.

Idiopathic restrictive cardiomyopathy in the young: report of two cases.

C. Rapezzi, B. Magnani, P. Ortolani, 1990, International journal of cardiology.

On the value of the activated clotting time for monitoring heparin therapy in acute coronary syndromes.

A. Branzi, B. Magnani, G. Melandri, 1993, The American journal of cardiology.

Malignant vasovagal syncope: a randomised trial of metoprolol and clonidine.

G. Boriani, M. Biffi, A. Branzi, 1997, Heart.

Evaluation of the effect of timolol alone and in combination with hydrochlorothiazide and amiloride in the treatment of mild to moderate arterial hypertension: a double-blind, controlled study.

B. Magnani, E. Agabiti-Rosei, E. Ambrosioni, 1976, Clinical science and molecular medicine. Supplement.

The E.L.S.A. Trial: Protocol of a Randomized Trial to Explore the Differential Effect of Antihypertensive Drugs on Atherosclerosis in Hypertension

G. Mancia, A. Zanchetti, M. Safar, 1994, Journal of cardiovascular pharmacology.

Plasminogen Activator Italian Multicenter Study (PAIMS): comparison of intravenous recombinant single-chain human tissue-type plasminogen activator (rt-PA) with intravenous streptokinase in acute myocardial infarction.

B. Magnani, Bruno Magnani, 1989, Journal of the American College of Cardiology.

Clinical and hemodynamic effects of long-term administration of gallopamil in patients with coronary artery disease and normal or impaired left ventricular function.

R. Franchi, B. Magnani, M. Dondi, 1989, The American journal of cardiology.

Tolerability of long-term treatment with lercanidipine versus amlodipine and lacidipine in elderly hypertensives.

A. Zanchetti, B. Magnani, B. Trimarco, 2002, American journal of hypertension.

Prostacyclin in primary pulmonary hypertension.

B. Magnani, N. Galiè, Bruno Magnani, 1996, European heart journal.

Role of pharmacologic tests in the treatment of primary pulmonary hypertension.

A. Branzi, B. Magnani, G. Ussia, 1995, The American journal of cardiology.

[Precapillary pulmonary hypertension: effect of Captopril].

B. Magnani, N. Galiè, C. Magelli, 1982, Giornale italiano di cardiologia.

Effect of enoximone alone and in combination with metoprolol on myocardial function and energetics in severe congestive heart failure: Improvement in hemodynamic and metabolic profile

A. Branzi, C. Rapezzi, B. Magnani, 1993, Cardiovascular Drugs and Therapy.

Myocardial metabolic and hemodynamic effects of a sustained intravenous infusion of nifedipine with and without metoprolol in patients with unstable angina.

F. Fallani, A. Branzi, B. Magnani, 1991, American Heart Journal.

Radionuclide evaluation of ventricular function at rest and during exercise in double inlet ventricle.

C. Rapezzi, B. Magnani, F. Picchio, 1989, International journal of cardiology.

Effects of oral nisoldipine in ischemic heart disease. A radioisotopic study.

B. Magnani, M. Dondi, G. Melandri, 1986, Arzneimittel-Forschung.

Comparison of the effects of pharmacological therapy and a low-sodium diet on mild hypertension.

B. Magnani, E. Ambrosioni, F. Racco, 1976, Clinical science and molecular medicine. Supplement.

INDOBUFEN VERSUS ASPIRIN PLUS DIPYRIDAMOLE AFTER CORONARY-ARTERY BYPASS-SURGERY

O. Alfieri, M. Lemma, L. Angoli, 1991 .

[Enzymatic estimation of infarct size in patients undergoing thrombolytic therapy].

A. Branzi, B. Magnani, G. Melandri, 1988, Cardiologia.

Tocainide and metoprolol: An efficacious therapeutic combination in the treatment of premature ventricular beats

A. Capucci, G. Boriani, B. Magnani, 1989, Clinical cardiology.

A double-blind crossover comparison of flecainide and slow-release mexiletine in the treatment of stable premature ventricular complexes.

A. Capucci, G. Boriani, B. Magnani, 1991, International journal of clinical pharmacology research.

[Idiopathic restrictive cardiomyopathy: clinical, hemodynamic, histologic and prognostic profile].

A. Branzi, C. Rapezzi, B. Magnani, 1989, Cardiologia.

Conversion of Recent‐Onset Atrial Fibrillation to Sinus Rhythm: Effects of Different Drug Protocols

A. Capucci, G. Boriani, A. Branzi, 1998, Pacing and clinical electrophysiology : PACE.

Antiarrhythmic efficacy of propafenone: Evaluation of effective plasma levels following single and multiple doses

A. Capucci, B. Magnani, E. Ambrosioni, 2004, European Journal of Clinical Pharmacology.

The effects of enoximone (MDL-17043) on forearm venous circulation in healthy volunteers and patients with heart failure

A. Branzi, B. Magnani, G. Melandri, 2005, Heart and Vessels.

[Aortic dissection without intimal laceration: a case report and review of the problem].

R. Fattori, C. Rapezzi, B. Magnani, 1993, Cardiologia.

Calcium Antagonist Lacidipine Slows Down Progression of Asymptomatic Carotid Atherosclerosis: Principal Results of the European Lacidipine Study on Atherosclerosis (ELSA), a Randomized, Double-Blind, Long-Term Trial

G. Mancia, A. Zanchetti, M. Bond, 2002, Circulation.

Electrophysiologic properties of prenalterol.

A. Capucci, B. Magnani, G. Melandri, 1983, International journal of cardiology.

A Data Bank to Better Prognosis and Treatment of Infective Endocarditis

A. Gaspari, B. Magnani, E. Ambrosioni, 1985 .

HAEMODYNAMIC EFFECTS OF PRENALTEROL IN ACUTE MYOCARDIAL ISCHAEMIA IN OPEN CHEST PIGS

A. Branzi, B. Magnani, S. Specchia, 1983, Clinical and experimental pharmacology & physiology.

Side effects of antihypertensive drugs. Incidence and methods of collection.

B. Magnani, E. Ambrosioni, F. Costa, 1979, International journal of clinical pharmacology and biopharmacy.

Different pharmacologic treatment for converting recent-onset atrial fibrillation: Evaluation on 377 patients

A. Capucci, G. Boriani, M. Biffi, 1996 .

704-2 Comparative Relation of Neurohormonal Activation to Hemodynamics in Primary or Precapillary Secondary Pulmonary Hypertension

A. Branzi, B. Magnani, S. Boschi, 1995 .

Minimal effective concentration values of propafenone and 5-hydroxy-propafenone in acute and chronic therapy

A. Capucci, G. Boriani, B. Magnani, 2005, Cardiovascular Drugs and Therapy.

[Clinical significance of magnetic resonance and echocardiographic correlations in the evaluation of hypertrophic cardiomyopathy].

R. Fattori, C. Rapezzi, B. Magnani, 1994, La Radiologia medica.

Iomeprol and iopamidol in cardiac angiography: a randomised, double-blind, parallel-group comparison.

R. Fattori, B. Magnani, A. Marzocchi, 1994, European journal of radiology.

Cardiac disease after chest irradiation for Hodgkin's disease: incidence in 108 patients with long follow-up.

F. Prati, A. Branzi, B. Magnani, 1995, International journal of cardiology.

[Analysis of the diastolic function of the left ventricle by Doppler echocardiography in athletes engaged in competitive sports activities].

C. Rapezzi, B. Magnani, M. B. Bacchi Reggiani, 1989, Cardiologia.

Dipyridamole technetium-99m-2-methoxy isobutyl isonitrile tomoscintigraphic imaging for identifying diseased coronary vessels: comparison with thallium-201 stress-rest study.

R. Franchi, B. Magnani, M. Dondi, 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Intralymphocytic sodium in hypertensive patients: a significant correlation.

B. Magnani, E. Ambrosioni, L. Montebugnoli, 1979, Clinical science.

Intralymphocytic sodium concentration as an index of response to stress and exercise in young subjects with borderline hypertension.

B. Magnani, E. Ambrosioni, C. Borghi, 1981, Clinical science.

[Paroxysmal atrial fibrillation: study of the pattern of onset using dynamic electrocardiography].

A. Capucci, G. Boriani, B. Magnani, 1989, Cardiologia.

Risk factors associated with alterations in carotid intima—media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis

Giuseppe Mancia, G. Mancia, A. Zanchetti, 1998, Journal of hypertension.

Beta-adrenergic blocking agents in the management of hypertension and angina pectoris

B. Magnani, 1974 .

Cardioselectivity and Partial Agonist Activity in the Antianginal Efficacy of the β-Adrenoceptor Antagonists

B. Magnani, E. Ambrosioni, S. Gubelli, 1983, Drugs.

Comparison of Antihypertensive Efficacy of Atenolol, Oxprenolol and Pindolol at Rest and during Exercise

B. Magnani, E. Ambrosioni, L. Montebugnoli, 1983, Drugs.

Oral Propafenone To Convert Recent-Onset Atrial Fibrillation in Patients with and without Underlying Heart Disease

A. Capucci, G. Boriani, M. Biffi, 1997, Annals of Internal Medicine.

A controlled study on oral propafenone versus digoxin plus quinidine in converting recent onset atrial fibrillation to sinus rhythm.

A. Capucci, G. Boriani, B. Magnani, 1994, International journal of cardiology.

[Valvular lesions in the course of nonpenetrating thoracic trauma: their diagnosis by transesophageal echocardiography].

C. Rapezzi, B. Magnani, G. Ussia, 1996, Cardiologia.

Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension.

A. Capucci, G. Boriani, B. Magnani, 1992, The American journal of cardiology.

Electrophysiological effects of flecainide and propafenone on atrial fibrillation cycle and relation with arrhythmia termination

A. Capucci, G. Boriani, M. Biffi, 1999, Heart.

Myocardial ischemia in pediatric age: clinical pictures and non-invasive assessment

C. Rapezzi, B. Magnani, M. Ferlito, 1987 .

Oral Loading with Propafenone: A Placebo‐Controlled Study in Elderly and Nonelderly Patients with Recent Onset Atrial Fibrillation

A. Capucci, G. Boriani, M. Biffi, 1998, Pacing and clinical electrophysiology : PACE.

Results of coronary stenting for unstable versus stable angina pectoris.

A. Branzi, B. Magnani, T. Palmerini, 1997, The American journal of cardiology.

Pharmacological treatment of atrial fibrillation: a review on prevention of recurrences and control of ventricular response.

G. Boriani, M. Biffi, A. Branzi, 1998, Archives of gerontology and geriatrics.

[Multiple coronary fistulas to the left ventricle. An unusual cause of myocardial ischemia].

B. Magnani, G. Melandri, A. Marzocchi, 1989, Cardiologia.

Influence on Water and Solutes Excretion Determined by Different Administrations of Muzolimine and Furosemide in Patients with Congestive Heart Failure

B. Magnani, V. Cervi, F. Tartagni, 1987 .

The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction

B. Magnani, E. Ambrosioni, C. Borghi, 1995 .

Haemodynamic effects of short term intravenous amiodarone for hypertrophic cardiomyopathy.

A. Branzi, C. Rapezzi, B. Magnani, 1988, British heart journal.

Haemodynamic effects ofshort termintravenous amiodarone forhypertrophic cardiomyopathy

A. Branzi, C. Rapezzi, B. Magnani, 1988 .

Percutaneous transluminal coronary angioplasty of the very proximal left anterior descending artery lesions: immediate results and follow-up.

F. Prati, R. Fattori, B. Magnani, 1991, International journal of cardiology.

Coronary stenting with the half (disarticulated) Palmaz-Schatz stent: immediate results and six-month follow-up.

A. Branzi, B. Magnani, T. Palmerini, 1997, Catheterization and cardiovascular diagnosis.

Propafenone for conversion of recent-onset atrial fibrillation. A controlled comparison between oral loading dose and intravenous administration.

A. Capucci, G. Boriani, B. Magnani, 1995, Chest.

Relationships Between Debrisoquine Hydroxylation and Propafenone Pharmacokinetics

A. Capucci, B. Magnani, E. Strocchi, 1990 .

Ventricular fibrillation after intravenous amiodarone in Wolff-Parkinson-White syndrome with atrial fibrillation.

A. Capucci, G. Boriani, M. Biffi, 1996, American heart journal.

Haemodynamic Effects of Dobutamine in Patients with Coronary Artery Disease

A. Branzi, B. Magnani, E. Ambrosioni, 1977, The Journal of international medical research.

Converting enzyme inhibition and heart failure.

B. Magnani, 1988, The American journal of medicine.

Lack of effect of captopril on serum digoxin in congestive heart failure

B. Magnani, M. Ribani, E. Ambrosioni, 2004, European Journal of Clinical Pharmacology.

The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators.

B. Magnani, E. Ambrosioni, C. Borghi, 1995, The New England journal of medicine.

Prognosis of Asymptomatic Patients With Hypertrophic Cardiomyopathy and Nonsustained Ventricular Tachycardia

C. Autore, P. Bruzzi, A. Branzi, 1994, Circulation.

Snoring every night as a risk factor for myocardial infarction: a case-control study.

B. Magnani, E. Lugaresi, R. D'alessandro, 1990, BMJ.

Long-term antihypertensive, metabolic and cellular effects of enalapril.

B. Magnani, P. Malini, E. Strocchi, 1984, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

Evaluation by Cardiopulmonary Exercise Test of DDDR Versus DDD Pacing

A. Capucci, G. Boriani, B. Magnani, 1992, Pacing and clinical electrophysiology : PACE.

Genetic heterogeneity of hypertrophic cardiomyopathy.

M. Devoto, A. Branzi, B. Magnani, 1985, International journal of cardiology.

Primary Pulmonary Hypertension

A. Branzi, B. Magnani, A. Manes, 1998 .

Cardioverter-defibrillator oversensing due to double counting of ventricular tachycardia electrograms.

G. Boriani, M. Biffi, A. Branzi, 1998, International journal of cardiology.

Intravenous diltiazem in patients with paroxysmal re-entrant supraventricular tachycardia.

A. Capucci, B. Magnani, C. Cavallini, 1989, International journal of cardiology.

Flecainide: evidence of non-linear kinetics

A. Capucci, G. Boriani, B. Magnani, 2004, European Journal of Clinical Pharmacology.

The Verapamil in Hypertension and Atherosclerosis Study (VHAS): Results of long‐term randomized treatment with either verapamil or chlorthalidone on carotid intima‐media thickness

A. Zanchetti, B. Magnani, A. Pessina, 1998, Journal of hypertension.

β-Blocking Properties of Propafenone in Extensive Oxidisers: A Study on Heart Rate Behaviour during Holter Monitoring

A. Capucci, G. Boriani, M. Biffi, 1993 .

Clinical results of the Verapamil inHypertension and Atherosclerosis Study. VHAS Investigators.

A. Zanchetti, B. Magnani, A. Pessina, 1997, Journal of hypertension.

Hospitalization for congestive heart failure: is it still a cardiology business?

A. Branzi, L. Potena, B. Magnani, 2002, European journal of heart failure.

Case 1: Primary Metabolic Cardiomyopathy Mimicking an Ischemic Heart Disease

B. Magnani, G. Cenacchi, F. Tartagni, 1986 .

Flecainide acetate: concentration-response relationships for antiarrhythmic and electrocardiographic effects.

A. Capucci, G. Boriani, M. Biffi, 1993, International journal of clinical pharmacology research.

Felodipine in severe chronic congestive heart failure: Acute effects on central hemodynamics and regional blood flow distribution

B. Magnani, V. Cervi, E. Varani, 1989, Cardiovascular Drugs and Therapy.

[Significance of the positivity of exercise myocardial scintigraphy in patients with normal coronary arteries: clinico-instrumental correlates].

R. Franchi, B. Magnani, G. Melandri, 1986, Cardiologia.

Neurocirculatory asthenia: a reassessment using modern psychosomatic criteria

B. Magnani, G. Fava, S. Grandi, 1994, Acta psychiatrica Scandinavica.

Favorable effects of flecainide in transvenous internal cardioversion of atrial fibrillation.

A. Capucci, G. Boriani, M. Biffi, 1999, Journal of the American College of Cardiology.

964-8 Oral Loading with Propafenone in Recent-Onset Atrial Fibrillation: A Controlled Evaluation on 240 Patients

A. Capucci, G. Boriani, B. Magnani, 1995 .

Severe postcardiac-transplant rejection associated with recurrence of giant cell myocarditis.

B. Magnani, O. Leone, C. Magelli, 1996, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

Cardiac neurosis and psychopathology.

B. Magnani, G. Fava, S. Grandi, 1989, Psychotherapy and Psychosomatics.

Evaluation of Atrial Refractoriness and Atrial Fibrillation Inducibility Immediately after Internal Cardioversion in Patients with Chronic Persistent Atrial Fibrillation

G. Boriani, M. Biffi, A. Branzi, 1999, Cardiovascular Drugs and Therapy.

Limitation of Myocardial Infarct Size by Nicorandil After Sustained Ischemia in Pigs

A. Branzi, B. Magnani, M. Zimarino, 1995, Journal of cardiovascular pharmacology.

[Restenosis after coronary angioplasty: its pathogenesis and prevention].

R. Fattori, A. Branzi, B. Magnani, 1991, Cardiologia.

Total body potassium and long-term treatment with amiloride HCL and/or hydrochlorothiazide.

B. Magnani, E. Ambrosioni, G. Melandri, 1979, International journal of clinical pharmacology and biopharmacy.

Human immunodeficiency virus type 1 antigen detection in endomyocardial biopsy: an immunomorphological study.

C. Rapezzi, B. Magnani, M. Re, 1990, Microbiologica.

Renal haemodynamics after chronic treatment with labetalol and propranolol.

B. Magnani, P. Malini, E. Strocchi, 1982, British journal of clinical pharmacology.

[Pharmacologic cardioversion with propafenone of stable atrial fibrillation of recent onset].

A. Capucci, B. Magnani, L. Frabetti, 1987, Giornale italiano di cardiologia.

Metabolic effects of long-term piretanide use

B. Magnani, V. Cervi, F. Tartagni, 1986 .

Stress and distress in essential hypertension.

B. Magnani, G. Trombini, R. M. Osti, 1980, Psychotherapy and psychosomatics.

Myocardial, coronary, and peripheral effects of xamoterol (ICI 118,587) in open-chest pigs

A. Branzi, B. Magnani, R. Zannoli, 2005, Cardiovascular Drugs and Therapy.

[Cardiac involvement in HIV infection].

C. Rapezzi, B. Magnani, P. Ortolani, 1989, Cardiologia.

Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa.

B. Magnani, P. Malini, E. Strocchi, 1983, International journal of clinical pharmacology research.

Atrial premature beats coupling interval determines lone paroxysmal atrial fibrillation onset.

A. Capucci, G. Boriani, B. Magnani, 1992, International journal of cardiology.

The Role of Infarct Size in Early and Late Mortality

B. Magnani, G. Melandri, 1989, Journal of cardiovascular pharmacology.

Plaque Hypertension Lipid-Lowering Italian Study (PHYLLIS): A protocol for non-invasive evaluation of carotid atherosclerosis in hypercholesterolaemic hypertensive subjects

G. Parati, G. Mancia, G. Gallus, 1993 .

Coronary stenting for unstable angina: predictors of 30-day and long-term clinical outcome.

A. Branzi, B. Magnani, T. Palmerini, 1999, Coronary artery disease.

[Hemodynamic effects of disopyramide and procainamide in open-chest animals].

A. Branzi, B. Magnani, P. Malini, 1978, Giornale italiano di cardiologia.

Conversion of recent-onset atrial fibrillation by a single oral loading dose of propafenone or flecainide.

A. Capucci, G. Boriani, B. Magnani, 1994 .